abbvie glp-1 Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic AbbVie licenses obesity drug from
Pay in 4 interest-free payments of $5.56 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6























